Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 8, 2008 - Issue 5
Submit an article Journal homepage
166
Views
12
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Maintenance therapy to prevent recurrence of depression: summary and implications of the PREVENT study

Susan G Kornstein Mood Disorders Institute, Executive Director, Institute for Women’s Health, Department of Psychiatry, Virginia Commonwealth University, PO Box 980710, Richmond, VA 23298, USA. [email protected]
Pages 737-742 | Published online: 09 Jan 2014

References

  • Solomon DA, Keller MB, Leon AC et al. Multiple recurrences of major depressive disorder. Am. J. Psychiatry157(2), 229–233 (2000).
  • Mueller TI, Leon AC, Keller MB et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am. J. Psychiatry156(7), 1000–1006 (1999).
  • Hollon SD, Shelton RC, Wisniewski S et al. Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. J. Psychiatr. Res.40(1), 59–69 (2006).
  • Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol. Psychiatry44(5), 348–360 (1998).
  • Keller MB, Lavori PW, Lewis CE, Klerman GL. Predictors of relapse in major depressive disorder. JAMA250(24), 3299–3304 (1983).
  • American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder (Second Edition). American Psychiatric Association, Arlington, VA, USA, vii-87 (2000).
  • Gelenberg AJ, Trivedi MH, Rush AJ et al. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression. Biol. Psychiatry54(8), 806–817 (2003).
  • Gilaberte I, Montejo AL, de la Gandara J et al. Fluoxetine in the prevention of depressive recurrences: a double-blind study. J. Clin. Psychopharmacol.21(4), 417–424 (2001).
  • Klysner R, Bent-Hansen J, Hansen HL et al. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br. J. Psychiatry181, 29–35 (2002).
  • Montgomery SA, Entsuah R, Hackett D, Kunz NR, Rudolph RL. Venlafaxine versus placebo in the preventive treatment of recurrent major depression. J. Clin. Psychiatry65, 328–336 (2004).
  • Rouillon F, Warner B, Pezous N, Bisserbe JC. Milnacipran efficacy in the prevention of recurrent depression: a 12-month placebo-controlled study. Milnacipran recurrence prevention study group. Int. Clin. Psychopharmacol.15(3), 133–140 (2000).
  • Frank E, Kupfer DJ, Perel JM et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry47(12), 1093–1099 (1990).
  • Keller MB, Kocsis JH, Thase ME et al. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA280(19), 1665–1672 (1998).
  • Kupfer DJ, Frank E, Perel JM et al. Five-year outcome for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry49(10), 769–773 (1992).
  • Reynolds CF III, Dew MA, Pollock BG et al. Maintenance treatment of major depression in old age. N. Engl. J. Med.354(11), 1130–1138 (2006).
  • Keller MB, Trivedi MH, Thase ME et al. The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the acute and continuation phases. Biol. Psychiatry62(12), 1371–1379 (2007).
  • Kocsis JH, Thase ME, Trivedi MH et al. Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J. Clin. Psychiatry68(7), 1014–1023 (2007).
  • Keller M, Trivedi MH, Thase ME et al. The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the two-year and combined maintenance phases. J. Clin. Psychiatry68(8), 1246–1256 (2007).
  • Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry23, 56–62 (1960).
  • Kornstein SG, Sloan DM. Risk of recurrence during long-term antidepressant treatment. (11 Question-and-answer forum). CNS Spectr.2, 1–8 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.